Blood direct PCR: impact of CYP2C19 and CYP4F2 variants for bleeding prediction in ST-elevation myocardial infarction patients with ticagrelor

Blood direct PCR: impact of CYP2C19 and CYP4F2 variants for bleeding prediction in ST-elevation myocardial infarction patients with ticagrelor

Aims: The goals of this study were to develop a new technique that could pave the way for a quicker determination of CYP4F2 rs3093135 and CYP2C19 rs4244285 variants directly from a patient's blood and to attempt to apply this technique in clinical practice. Patients & methods: The study inc...

Full description

Bibliographic Details
Main Authors: Aldujeli, A. (Author), Baksyte, G. (Author), Burkanas, M. (Author), Ciapiene, I. (Author), Giedraitiene, A. (Author), Gustiene, O. (Author), Kurnickaite, Z. (Author), Lesauskaite, V. (Author), MacIulevicius, L. (Author), Norvilaite, R. (Author), Sakalyte, G. (Author), Skipskis, V. (Author), Tatarunas, V. (Author), Unikas, R. (Author), Venius, J. (Author)
Format: Article
Language:English
Published: Future Medicine Ltd. 2022
Subjects:
acute coronary syndrome
antiplatelets
blood direct PCR
CYP2C19
CYP4F2
personalization
STEMI
ticagrelor
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items